Telesis Bio Stock Analysis

TBIO Stock  USD 3.89  0.04  1.04%   
Telesis Bio is fairly valued with Real Value of 3.81 and Target Price of 4.0. The main objective of Telesis Bio stock analysis is to determine its intrinsic value, which is an estimate of what Telesis Bio is worth, separate from its market price. There are two main types of Telesis Bio's stock analysis: fundamental analysis and technical analysis.
The Telesis Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Telesis Bio is usually not traded on Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. Telesis Stock trading window is adjusted to America/New York timezone.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telesis Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Telesis Stock, please use our How to Invest in Telesis Bio guide.

Telesis Stock Analysis Notes

About 38.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 28.29. Telesis Bio had not issued any dividends in recent years. The entity had 1:18 split on the 9th of May 2024. Translate Bio, Inc., a clinical-stage messenger RNA therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company was founded in 2011 and is headquartered in Lexington, Massachusetts. Translate Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people. To find out more about Telesis Bio contact Dr MBA at 858 228 4115 or learn more at https://telesisbio.com.

Telesis Bio Quarterly Total Revenue

3.44 Million

Telesis Bio Investment Alerts

Telesis Bio generated a negative expected return over the last 90 days
Telesis Bio has high historical volatility and very poor performance
Telesis Bio has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 27.51 M. Net Loss for the year was (47.72 M) with profit before overhead, payroll, taxes, and interest of 15.6 M.
Telesis Bio currently holds about 654.75 M in cash with (34.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Telesis Bio has a poor financial position based on the latest SEC disclosures
Roughly 38.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Disposition of 18900 shares by Demetri George of Telesis Bio at 15.33 subject to Rule 16b-3

Telesis Bio Upcoming and Recent Events

Earnings reports are used by Telesis Bio to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
19th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
19th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Telesis Largest EPS Surprises

Earnings surprises can significantly impact Telesis Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-11-05
2020-09-300.20.230.0315 
2023-08-10
2023-06-30-0.32-0.280.0412 
2019-11-06
2019-09-30-0.46-0.410.0510 
View All Earnings Estimates

Telesis Bio Environmental, Social, and Governance (ESG) Scores

Telesis Bio's ESG score is a quantitative measure that evaluates Telesis Bio's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Telesis Bio's operations that may have significant financial implications and affect Telesis Bio's stock price as well as guide investors towards more socially responsible investments.

Telesis Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.55 M.

Telesis Profitablity

The company has Profit Margin (PM) of (1.84) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.48) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.48.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.73)(0.76)
Return On Capital Employed(0.56)(0.59)
Return On Assets(0.68)(0.71)
Return On Equity(1.62)(1.53)

Management Efficiency

Telesis Bio has return on total asset (ROA) of (0.2681) % which means that it has lost $0.2681 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5529) %, meaning that it created substantial loss on money invested by shareholders. Telesis Bio's management efficiency ratios could be used to measure how well Telesis Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of the 18th of July 2024, Return On Tangible Assets is likely to drop to -0.76. In addition to that, Return On Capital Employed is likely to drop to -0.59. At this time, Telesis Bio's Asset Turnover is very stable compared to the past year.
Last ReportedProjected for Next Year
Book Value Per Share 0.99  1.04 
Tangible Book Value Per Share 0.83  0.87 
Enterprise Value Over EBITDA(7.95)(8.35)
Price Book Value Ratio 7.26  7.62 
Enterprise Value Multiple(7.95)(8.35)
Price Fair Value 7.26  7.62 
Enterprise Value247 M234.6 M
The analysis of Telesis Bio's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Telesis Bio's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Telesis Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Operating Margin
(2.48)
Profit Margin
(1.84)
Beta
1.743
Return On Assets
(0.27)
Return On Equity
(1.55)

Technical Drivers

As of the 18th of July 2024, Telesis Bio has the Variance of 85.2, risk adjusted performance of (0.03), and Coefficient Of Variation of (1,683). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Telesis Bio, as well as the relationship between them.

Telesis Bio Price Movement Analysis

Execute Study
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Telesis Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Telesis Bio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Telesis Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Telesis Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Telesis Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Telesis Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Telesis Bio Predictive Daily Indicators

Telesis Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Telesis Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Telesis Bio Forecast Models

Telesis Bio's time-series forecasting models are one of many Telesis Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Telesis Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Telesis Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Telesis Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Telesis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Telesis Bio. By using and applying Telesis Stock analysis, traders can create a robust methodology for identifying Telesis entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(1.73)(1.82)
Operating Profit Margin(1.28)(1.34)
Net Loss(1.73)(1.82)
Gross Profit Margin 0.47  0.49 

Current Telesis Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Telesis analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Telesis analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
4.0Strong Buy1Odds
Telesis Bio current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Telesis analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Telesis stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Telesis Bio, talking to its executives and customers, or listening to Telesis conference calls.
Telesis Analyst Advice Details

Telesis Stock Analysis Indicators

Telesis Bio stock analysis indicators help investors evaluate how Telesis Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Telesis Bio shares will generate the highest return on investment. By understating and applying Telesis Bio stock analysis, traders can identify Telesis Bio position entry and exit signals to maximize returns.
Begin Period Cash Flow30.6 M
Long Term Debt5.3 M
Common Stock Shares Outstanding29.8 M
Total Stockholder Equity29.5 M
Tax Provision27 K
Property Plant And Equipment Net34.5 M
Cash And Short Term Investments19.3 M
Cash1.7 M
Accounts Payable3.3 M
Net Debt32.6 M
50 Day M A4.1127
Total Current Liabilities8.2 M
Other Operating Expenses62.7 M
Non Current Assets Total40.1 M
Non Currrent Assets Other676 K
Stock Based CompensationM

Additional Information and Resources on Investing in Telesis Stock

When determining whether Telesis Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Telesis Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Telesis Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Telesis Bio Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telesis Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Telesis Stock, please use our How to Invest in Telesis Bio guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Telesis Bio. If investors know Telesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Telesis Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(28.29)
Revenue Per Share
14.803
Quarterly Revenue Growth
(0.46)
Return On Assets
(0.27)
Return On Equity
(1.55)
The market value of Telesis Bio is measured differently than its book value, which is the value of Telesis that is recorded on the company's balance sheet. Investors also form their own opinion of Telesis Bio's value that differs from its market value or its book value, called intrinsic value, which is Telesis Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Telesis Bio's market value can be influenced by many factors that don't directly affect Telesis Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Telesis Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Telesis Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Telesis Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.